Benzyl chloride


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:3458959IVR50 mg/kg 50 mg/kgHepatocellular carcinomaEndocrine-mediated cancer;Hepatic endocrine-mediated perturbations
IVR250 mg/kg 250 mg/kgAffects survival of live fetusReproductive endocrine-mediated perturbations
IVR50 mg/kg 50 mg/kgChanges in morphology of thyroid glandMetabolic endocrine-mediated perturbations
IVR6.3 mg/kg -No significant effects observed-
IVR62 mg/kg -No significant effects observed-
IVR12.5 mg/kg -No significant effects observed-
IVR30 mg/kg -No significant effects observed-
IVR25 mg/kg -No significant effects observed-
IVR15 mg/kg -No significant effects observed-
IVR100 mg/kg 100 mg/kgHemangioma in spleenEndocrine-mediated cancer;Immunological endocrine-mediated perturbations
IVR100 mg/kg 100 mg/kgHepatocellular carcinomaEndocrine-mediated cancer;Hepatic endocrine-mediated perturbations
IVR125 mg/kg 125 mg/kgAffects survival of live fetusReproductive endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.